Evidence map›Paper›PMID 35364700›Full record

ReviewVirchows Archiv : an international journal of pathology2022

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Danny Jonigk, Christopher Werlein, Till Acker, Martin Aepfelbacher, Kerstin U Amann, Gustavo Baretton, Peter Barth, Rainer M Bohle, Andreas Büttner, Reinhard Büttner and 47 more

Open access · hybridAbstract readReview
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. A survey of SARS-CoV-2 tropism.Infectious diseases & immunity · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Neuropathological features of SARS-CoV-2 delta and omicron variants.Journal of neuropathology and experimental neurology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Microvascular Thrombosis as a Critical Factor in Severe COVID-19.International journal of molecular sciences · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

57 authors at 20 institutions in 1 country.

Danny Jonigk *Institute of Pathology, Hannover Medical School, Hannover, Germany. jonigk.danny@mh-hannover.de.
Christopher Werlein *Institute of Pathology, Hannover Medical School, Hannover, Germany.
Till AckerInstitute of Neuropathology, University Hospital Giessen and Marburg, Giessen, Germany.
Martin AepfelbacherInstitute of Medical Microbiology, Virology, and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kerstin U AmannDepartment of Nephropathology, University Hospital Erlangen-Nürnberg, Erlangen, Germany.
Gustavo BarettonDepartment of Pathology, University Hospital Dresden, Dresden, Germany.
Peter BarthGerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany.
Rainer M BohleDepartment of Pathology, University Hospital Saarland Homburg, Homburg, Germany.
Andreas BüttnerInstitute of Forensic Medicine, University Medical Center Rostock, Rostock, Germany.
Reinhard BüttnerDepartment of Pathology, University Hospital Cologne, Cologne, Germany.
Reinhard DettmeyerDepartment of Legal Medicine, University Hospital Giessen and Marburg, Giessen, Germany.
Philip EichhornDepartment of Pathology, University Hospital Erlangen-Nürnberg, Erlangen, Germany.
Sefer ElezkurtajDepartment of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Irene EspositoDepartment of Pathology, University Hospital Düsseldorf, Düsseldorf, Germany.
Katja EvertDepartment of Pathology, University Hospital Regensburg, Regensburg, Germany.
Matthias EvertDepartment of Pathology, University Hospital Regensburg, Regensburg, Germany.
Falko FendDepartment of Pathology, University Hospital Tübingen, Tübingen, Germany.
Nikolaus GaßlerDepartment of Pathology, University Hospital Jena, Jena, Germany.
Stefan GattenlöhnerDepartment of Pathology, University Hospital Giessen and Marburg, Giessen, Germany.
Markus GlatzelInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Heike GöbelDepartment of Pathology, University Hospital Cologne, Cologne, Germany.
Elise GradhandSenckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
Torsten HansenDepartment of Pathology, University Hospital OWL of the Bielefeld University, Campus Lippe, Detmold, Germany.
Arndt HartmannDepartment of Pathology, University Hospital Erlangen-Nürnberg, Erlangen, Germany.
Axel HeinemannDepartment of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Frank L HeppnerDepartment of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Julia HilsenbeckDepartment of Pathology, University Hospital Dresden, Dresden, Germany.
David HorstDepartment of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jan C KampDepartment of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Gita MallDepartment of Legal Medicine, University Hospital Jena, Jena, Germany.
Bruno MärklGeneral Pathology and Molecular Diagnostics, University Hospital Augsburg, Augsburg, Germany.
Benjamin OndruschkaInstitute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jessica PablikDepartment of Pathology, University Hospital Dresden, Dresden, Germany.
Susanne PfefferleInstitute of Medical Microbiology, Virology, and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alexander QuaasDepartment of Pathology, University Hospital Cologne, Cologne, Germany.
Helena RadbruchDepartment of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Christoph RöckenDepartment of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
Andreas RosenwaldInstitute of Pathology, University of Würzburg, Würzburg, Germany.
Wilfried RothDepartment of Pathology, University Medical Center Mainz, Mainz, Germany.
Martina RudeliusInstitute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Peter SchirmacherDepartment of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Julia Slotta-HuspeninaDepartment of Pathology, TUM School of Medicine of Technical University of Munich, Munich, Germany.
Kevin SmithSenckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
Linna SommerDepartment of Pathology, University Hospital Dresden, Dresden, Germany.
Konrad StockDepartment of Nephrology, TUM School of Medicine of Technical University of Munich, Munich, Germany.
Philipp StröbelDepartment of Pathology, University Medical Center Göttingen, Göttingen, Germany.
Stephanie StroblDepartment of Pathology, University Medical Center Mainz, Mainz, Germany.
Ulf TitzeDepartment of Pathology, University Hospital OWL of the Bielefeld University, Campus Lippe, Detmold, Germany.
Gregor WeirichDepartment of Pathology, TUM School of Medicine of Technical University of Munich, Munich, Germany.
Joachim WeisDepartment of Neuropathology, University Hospital RWTH Aachen, Aachen, Germany.
Martin WernerInstitute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.
Claudia WickenhauserDepartment of Pathology, University Hospital Halle (Saale), Halle (Saale), Germany.
Thorsten WiechDepartment of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Peter WildSenckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
Tobias WelteDepartment of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Saskia von Stillfried *Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Peter Boor *Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany. pboor@ukaachen.de.ORCID http://orcid.org/0000-0001-9921-4284
Universität Hamburg · DEMedizinische Hochschule Hannover · DEGoethe University Frankfurt · DEHumboldt-Universität zu Berlin · DETechnical University of Munich · DEUniversitätsklinikum Gießen und Marburg · DEUniversity Hospital Cologne · DEBielefeld University · DEJena University Hospital · DEJohannes Gutenberg University Mainz · DERWTH Aachen University · DEUniversitätsklinikum Erlangen · DEUniversity Hospital Regensburg · DEDüsseldorf University Hospital · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Center for Neurodegenerative Diseases · DEHeidelberg University · DELudwig-Maximilians-Universität München · DESaarland University · DEUniversitätsklinikum Aachen · DE

Funding

Bundesministerium für Bildung und Forschung 01KX2021Bundesministerium für Gesundheit ZMVI1-2520COR201
6 · The paper itself

Abstract

The use of autopsies in medicine has been declining. The COVID-19 pandemic has documented and rejuvenated the importance of autopsies as a tool of modern medicine. In this review, we discuss the various autopsy techniques, the applicability of modern analytical methods to understand the pathophysiology of COVID-19, the major pathological organ findings, limitations or current studies, and open questions. This article summarizes published literature and the consented experience of the nationwide network of clinical, neuro-, and forensic pathologists from 27 German autopsy centers with more than 1200 COVID-19 autopsies. The autopsy tissues revealed that SARS-CoV-2 can be found in virtually all human organs and tissues, and the majority of cells. Autopsies have revealed the organ and tissue tropism of SARS-CoV-2, and the morphological features of COVID-19. This is characterized by diffuse alveolar damage, combined with angiocentric disease, which in turn is characterized by endothelial dysfunction, vascular inflammation, (micro-) thrombosis, vasoconstriction, and intussusceptive angiogenesis. These findings explained the increased pulmonary resistance in COVID-19 and supported the recommendations for antithrombotic treatment in COVID-19. In contrast, in extra-respiratory organs, pathological changes are often nonspecific and unclear to which extent these changes are due to direct infection vs. indirect/secondary mechanisms of organ injury, or a combination thereof. Ongoing research using autopsies aims at answering questions on disease mechanisms, e.g., focusing on variants of concern, and future challenges, such as post-COVID conditions. Autopsies are an invaluable tool in medicine and national and international interdisciplinary collaborative autopsy-based research initiatives are essential.

Indexed as

COVID-19AutopsyHumansLungPandemicsSARS-CoV-2Acute kidney damageDiffuse alveolar damageImmune responseSARS-CoV-2

Identifiers

PMID35364700
PMCPMC8975445
OpenAlexW4226138484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.